INCIDENCE AND EXTENT OF CANCER TREATEMENT RELATED CARDIOTOXICITY OF BREAST CANCER PATIENTS

ECG changes as Cardiac Toxicity of Concurrent Trustuzumab and Paclitaxel in Adjuvant Treatment of HER-2 positive Breast Cancer

The Impact of Trastuzumab Administration Patterns on the Long-Term Clinical Outcomes of Patients with Non-Metastatic Breast Cancer in a Resource-Limited Setting

Retrospective Study of Cardiac Toxicity of Hypofractionated Radiotherapy in Left Sided Breast Cancer

The Use of Trastuzumab in Metastatic Breast Cancer

Prevalence and Risk Factors of Cardiotoxicity in Elderly Cancer Patients

Targeted Treatment Trastuzumab is found to greatly Improve Long Term Survival of HER2 Breast Cancer Patients

Cyclophosphamide-induced cardiotoxicity

The Effect of Cardiac Rehabilitation on Quality of Life and 6-Minute Walk Test in Breast Cancer Patients During Ongoing Anthracycline Based Therapy

PRECLINICAL DETECTION OF CHEMOTHERAPY INDUCED LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CANCER COLON BY TRANSTHORACIC ECHOCARDIOGRAPHY